Results 151 to 160 of about 893,246 (219)

Multi‐omics profiling of chronic immune‐mediated skin diseases: SKINERGY protocol and strategic evaluation

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 40, Issue 9, Page 1490-1501, September 2026.
The SKINERGY study will investigate six immune‐mediated inflammatory skin diseases through a nationwide collaboration across all Dutch university medical centres. Involving 720 patients and 120 healthy volunteers, it is aimed at generating a high‐quality dataset to identify biomarkers that enable personalized treatment strategies and improved disease ...
N. G. Koster   +68 more
wiley   +1 more source

Vitamin B3 (Nicotinamide) Supplementation in Primary and Scleroderma-Related Raynaud Phenomenon. [PDF]

open access: yesACR Open Rheumatol
Govender M   +8 more
europepmc   +1 more source

Porto‐Sinusoidal Vascular Disorder‐Spectrum Portal Venopathy as a Structural Substrate for Portal Hypertension in Anti‐Centromere Antibody‐Positive Primary Biliary Cholangitis

open access: yesPathology International, Volume 76, Issue 9, September 2026.
Anti‐centromere antibody‐positive primary biliary cholangitis‐spectrum disease may present with portal hypertension disproportionate to liver stiffness. In this series of three patients, portal tract‐based histology showed portal venopathy with porto‐sinusoidal vascular disorder‐spectrum features, supported by venographic, elastographic, and ...
Yuya Ando   +6 more
wiley   +1 more source

Scleroderma: disease subtypes and multiorgan manifestations. [PDF]

open access: yesTrends Mol Med
Johnson NM, Hinchcliff ME, Odell ID.
europepmc   +1 more source

Treatment for systemic scleroderma

open access: yesСовременная ревматология, 2011
Rezvaya Tairovich Alekperov   +1 more
doaj   +3 more sources

Home - About - Disclaimer - Privacy